A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M

Nature Genetics

Volumn 37, Issue 9, 2005, Pages 958-963

  Meetei, Amom Ruhikanta ^a,b   Medhurst, Annette L ^c   Ling, Chen ^b   Xue, Yutong ^b   Singh, Thiyam Ramsing ^a   Bier, Patrick ^c   Steltenpool, Jurgen ^c   Stone, Stacie ^d   Dokal, Inderjeet ^e   Mathew, Christopher G ^f   Hoatlin, Maureen ^d   Joenje, Hans ^c   De Winter, Johan P ^c   Wang, Weidong ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; FANCD2 PROTEIN, HUMAN; FANCL PROTEIN, HUMAN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; HEMAGGLUTININ ESTERASE; LIGASE; NUCLEAR PROTEIN; UBIQUITIN; VIRUS FUSION PROTEIN; VIRUS HEMAGGLUTININ;

ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; GENETICS; HUMAN; HUMAN CELL; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PURIFICATION; UBIQUITINATION; ARCHAEBACTERIUM; CHEMISTRY; ENZYMOLOGY; EVOLUTION; IMMUNOPRECIPITATION; METABOLISM; MOLECULAR GENETICS; MUTATION; PHOSPHORYLATION; PROTEIN TRANSPORT;

ARCHAEA;

ARCHAEA; BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; DNA REPAIR; EVOLUTION; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP L PROTEIN; HEMAGGLUTININS, VIRAL; HUMANS; IMMUNOPRECIPITATION; LIGASES; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN TRANSPORT; UBIQUITIN; VIRAL FUSION PROTEINS;

EID: 25144449181     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1626     Document Type: Article

References (30)

1. Joenje, H. & Patel, K.J. The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet. 2, 446-459 (2001).
2. Garcia-Higuera, I. et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7, 249-262 (2001).
3. Howlett, N.G. et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297, 606-609 (2002).
4. Meetei, A.R. et al. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell. Biol. 23, 3417-3426 (2003).
5. Meetei, A.R. et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35, 165-170 (2003).
6. Meetei, A.R. et al. X-linked inheritance of Fanconi anemia complementation group B. Nat. Genet. 36, 1219-1224 (2004).
7. Taniguchi, T. & D'Andrea, A.D. The Fanconi anemia protein, FANGE, promotes the nuclear accumulation of FANCC. Blood 100, 2457-2462 (2002).
8. Bruun, D. et al. siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells. DNA Repair (Amst.) 2, 1007-1013 (2003).
9. Komori, K., Fujikane, R., Shinagawa, H. & Ishino, Y. Novel endonuclease in Archaea cleaving DNA with various branched structure. Genes Genet. Syst. 77, 227-241 (2002).
10. Komori, K. et al. Cooperation of the N-terminal Helicase and C-terminal endonuclease activities of Archaeal Hef protein in processing stalled replication forks. J. Biol. Chem. 279, 53175-53185 (2004).
11. Sgouros, J., Gaillard, P.M. & Wood, R.D. A relationship between a DNA-repair/recombination nuclease family and archaeal helicases. Trends Biochem. Sci. 24, 95-97 (1999).
12. Aravind, L., Walker, D.R. & Koonin, E.V. Conserved domains in DNA repair proteins and evolution of repair systems. Nucleic Acids Res. 27, 1223-1242 (1999).
13. Sijbers, A.M. et al. Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell 86, 811-822 (1996).
14. Mu, D., Hsu, D.S. & Sancar, A. Reaction mechanism of human DNA repair excision nuclease. J. Biol. Chem. 271, 8285-8294 (1996).
15. Enzlin, J.H. & Scharer, O.D. The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif. EMBO J. 21, 2045-2053 (2002).
16. Prakash, R. et al. Saccharomyces cerevisiae MPH1 gene, required for homologous recombination-mediated mutation avoidance, encodes a 3′ to 5′ DNA helicase. J. Biol. Chem. 280, 7854-7860 (2005).
17. Scheller, J., Schurer, A., Rudolph, C., Hettwer, S. & Kramer, W. MPH1, a yeast gene encoding a DEAH protein, plays a role in protection of the genome from spontaneous and chemically induced damage. Genetics 155, 1069-1081 (2000).
18. Schurer, K.A., Rudolph, C., Ulrich, H.D. & Kramer, W. Yeast MPH1 gene functions in an error-free DNA damage bypass pathway that requires genes from Homologous recombination, but not from postreplicative repair. Genetics 166, 1673-1686 (2004).
19. Zavitz, K.H. & Marians, K.J. ATPase-deficient mutants of the Escherichia coli DNA replication protein PriA are capable of catalyzing the assembly of active primosomes. J. Biol. Chem. 267, 6933-6940 (1992).
20. Sung, P., Higgins, D., Prakash, L. & Prakash, S. Mutation of lysine-48 to arginine in the yeast RAD3 protein abolishes its ATPase and DNA helicase activities but not the ability to bind ATP. EMBO J. 7, 3263-3269 (1988).
21. Van Komen, S., Petukhova, G., Sigurdsson, S., Stratton, S. & Sung, P. Superhelicity-driven homologous DNA pairing by yeast recombination factors Rad51 and Rad54. Mol. Cell 6, 563-572 (2000).
22. Havas, K. et al. Generation of superhelical torsion by ATP-dependent chromatin remodeling activities. Cell 103, 1133-1142 (2000).
23. Saha, A., Wittmeyer, J. & Cairns, B.R. Chromatin remodeling by RSC involves ATP-dependent DNA translocation. Genes Dev. 16, 2120-2134 (2002).
24. Levitus, M. et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat. Genet., advance online publication 21 August 2005 (doi:10.1038/ngl625).
25. Cantor, S. et al. The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. Proc. Natl. Acad. Sci. USA 101, 2357-2362 (2004).
26. Pichierri, P. & Rosselli, F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J. 23, 1178-1187 (2004).
27. Andreassen, P.R., D'Andrea, A.D. & Taniguchi, T. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev. 18, 1958-1963 (2004).
28. Levitus, M. et al. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. Blood 103, 2498-2503 (2004).
29. Demuth, I., Digweed, M. & Concannon, P. Human SNM1B is required for normal cellular response to both DNA interstrand crosslink-inducing agents and ionizing radiation. Oncogens 23, 8611-8618 (2004).
30. Xue, Y. et al. The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc. Natl. Acad. Sci. USA 100, 10635-10640 (2003).